Long-term Dupilumab Therapy in a Pediatric Patient with Netherton Syndrome: A Case Report and Review of the Literature
Asian Journal of Pediatric Dermatology · 2024
DOI: 10.4103/ajpd.ajpd_25_24 ↗Kurz gefasst
Fallbericht in der Zeitschrift Asian Journal of Pediatric Dermatology, 2024. Verfasst von Haleigh Dawn Stafford und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Netherton syndrome (NS) is an inherited ichthyosis without targeted therapies, and current treatment remains largely symptomatic. Herein, we report the case of a 6-year-old patient with NS successfully managed with dupilumab for 3 years. The literature regarding dupilumab treatment in this patient population is summarized, and the potential role of dupilumab in altering the pathogenesis of NS is discussed.
Zitieren
APA
Stafford, H. D., & Lee, G. L. (2024). Long-term Dupilumab Therapy in a Pediatric Patient with Netherton Syndrome: A Case Report and Review of the Literature. Asian Journal of Pediatric Dermatology. https://doi.org/10.4103/ajpd.ajpd_25_24
Vancouver
Stafford HD, Lee GL. Long-term Dupilumab Therapy in a Pediatric Patient with Netherton Syndrome: A Case Report and Review of the Literature. Asian Journal of Pediatric Dermatology. 2024. doi:10.4103/ajpd.ajpd_25_24
BibTeX
@article{Stafford2024,
author = {Stafford, Haleigh Dawn and Lee, Grace L.},
title = {Long-term Dupilumab Therapy in a Pediatric Patient with Netherton Syndrome: A Case Report and Review of the Literature},
journal = {Asian Journal of Pediatric Dermatology},
year = {2024},
doi = {10.4103/ajpd.ajpd_25_24}
}
EUVIMED